Achieve Life Sciences ACHV Change in fair value of contingent consideration
Change in fair value of contingent consideration at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.
The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's change in fair value of contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Achieve Life Sciences's change in fair value of contingent consideration?
- Achieve Life Sciences (ACHV) reported change in fair value of contingent consideration of -$285K in Q1 2026.
- How has Achieve Life Sciences's change in fair value of contingent consideration changed year-over-year?
- Achieve Life Sciences's change in fair value of contingent consideration decreased by 413.2% year-over-year, from $91K to -$285K.
- What is the long-term trend for Achieve Life Sciences's change in fair value of contingent consideration?
- Over 2 years (2023 to 2025), Achieve Life Sciences's change in fair value of contingent consideration has grown at a -12.1% compound annual growth rate (CAGR), from $528K to $408K.
- What does change in fair value of contingent consideration mean?
- The periodic adjustment to the fair value of liabilities associated with acquisition-related earn-outs or performance-based payments. Changes in this value reflect management's updated expectations regarding the likelihood of achieving specific business milestones.